Matches in SemOpenAlex for { <https://semopenalex.org/work/W2577432886> ?p ?o ?g. }
- W2577432886 endingPage "1188" @default.
- W2577432886 startingPage "1171" @default.
- W2577432886 abstract "Novel antimalarial therapeutics that target multiple stages of the parasite lifecycle are urgently required to tackle the emerging problem of resistance with current drugs. Here, we describe the optimization of the 2-anilino quinazoline class as antimalarial agents. The class, identified from publicly available antimalarial screening data, was optimized to generate lead compounds that possess potent antimalarial activity against P. falciparum parasites comparable to the known antimalarials, chloroquine and mefloquine. During the optimization process, we defined the functionality necessary for activity and improved in vitro metabolism and solubility. The resultant lead compounds possess potent activity against a multidrug resistant strain of P. falciparum and arrest parasites at the ring phase of the asexual stage and also gametocytogensis. Finally, we show that the lead compounds are orally efficacious in a 4 day murine model of malaria disease burden." @default.
- W2577432886 created "2017-01-26" @default.
- W2577432886 creator A5013131908 @default.
- W2577432886 creator A5015105620 @default.
- W2577432886 creator A5018238154 @default.
- W2577432886 creator A5037671006 @default.
- W2577432886 creator A5038235271 @default.
- W2577432886 creator A5038588871 @default.
- W2577432886 creator A5040184200 @default.
- W2577432886 creator A5042165950 @default.
- W2577432886 creator A5043314621 @default.
- W2577432886 creator A5049548979 @default.
- W2577432886 creator A5059081442 @default.
- W2577432886 creator A5061402800 @default.
- W2577432886 creator A5061968778 @default.
- W2577432886 creator A5065212330 @default.
- W2577432886 creator A5072487061 @default.
- W2577432886 creator A5075453403 @default.
- W2577432886 creator A5082452827 @default.
- W2577432886 date "2017-01-26" @default.
- W2577432886 modified "2023-09-27" @default.
- W2577432886 title "Optimization of 2-Anilino 4-Amino Substituted Quinazolines into Potent Antimalarial Agents with Oral in Vivo Activity" @default.
- W2577432886 cites W1014442399 @default.
- W2577432886 cites W1822821191 @default.
- W2577432886 cites W1967155346 @default.
- W2577432886 cites W1969503178 @default.
- W2577432886 cites W1975709468 @default.
- W2577432886 cites W1982190063 @default.
- W2577432886 cites W1985286323 @default.
- W2577432886 cites W1987574056 @default.
- W2577432886 cites W1988408916 @default.
- W2577432886 cites W1992193394 @default.
- W2577432886 cites W1993795323 @default.
- W2577432886 cites W2000388030 @default.
- W2577432886 cites W2008510296 @default.
- W2577432886 cites W2010116804 @default.
- W2577432886 cites W2010387696 @default.
- W2577432886 cites W2033634323 @default.
- W2577432886 cites W2034745024 @default.
- W2577432886 cites W2034938592 @default.
- W2577432886 cites W2037200829 @default.
- W2577432886 cites W2048080607 @default.
- W2577432886 cites W2053963776 @default.
- W2577432886 cites W2064734109 @default.
- W2577432886 cites W2068258025 @default.
- W2577432886 cites W2073901844 @default.
- W2577432886 cites W2080641616 @default.
- W2577432886 cites W2081640564 @default.
- W2577432886 cites W2083372859 @default.
- W2577432886 cites W2101904700 @default.
- W2577432886 cites W2106374535 @default.
- W2577432886 cites W2125851600 @default.
- W2577432886 cites W2128943039 @default.
- W2577432886 cites W2133913001 @default.
- W2577432886 cites W2161311583 @default.
- W2577432886 cites W2215440518 @default.
- W2577432886 cites W2262506123 @default.
- W2577432886 cites W2344935384 @default.
- W2577432886 cites W2408401628 @default.
- W2577432886 cites W928127617 @default.
- W2577432886 doi "https://doi.org/10.1021/acs.jmedchem.6b01673" @default.
- W2577432886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28080063" @default.
- W2577432886 hasPublicationYear "2017" @default.
- W2577432886 type Work @default.
- W2577432886 sameAs 2577432886 @default.
- W2577432886 citedByCount "39" @default.
- W2577432886 countsByYear W25774328862017 @default.
- W2577432886 countsByYear W25774328862018 @default.
- W2577432886 countsByYear W25774328862019 @default.
- W2577432886 countsByYear W25774328862020 @default.
- W2577432886 countsByYear W25774328862021 @default.
- W2577432886 countsByYear W25774328862022 @default.
- W2577432886 countsByYear W25774328862023 @default.
- W2577432886 crossrefType "journal-article" @default.
- W2577432886 hasAuthorship W2577432886A5013131908 @default.
- W2577432886 hasAuthorship W2577432886A5015105620 @default.
- W2577432886 hasAuthorship W2577432886A5018238154 @default.
- W2577432886 hasAuthorship W2577432886A5037671006 @default.
- W2577432886 hasAuthorship W2577432886A5038235271 @default.
- W2577432886 hasAuthorship W2577432886A5038588871 @default.
- W2577432886 hasAuthorship W2577432886A5040184200 @default.
- W2577432886 hasAuthorship W2577432886A5042165950 @default.
- W2577432886 hasAuthorship W2577432886A5043314621 @default.
- W2577432886 hasAuthorship W2577432886A5049548979 @default.
- W2577432886 hasAuthorship W2577432886A5059081442 @default.
- W2577432886 hasAuthorship W2577432886A5061402800 @default.
- W2577432886 hasAuthorship W2577432886A5061968778 @default.
- W2577432886 hasAuthorship W2577432886A5065212330 @default.
- W2577432886 hasAuthorship W2577432886A5072487061 @default.
- W2577432886 hasAuthorship W2577432886A5075453403 @default.
- W2577432886 hasAuthorship W2577432886A5082452827 @default.
- W2577432886 hasBestOaLocation W25774328861 @default.
- W2577432886 hasConcept C150903083 @default.
- W2577432886 hasConcept C185592680 @default.
- W2577432886 hasConcept C203014093 @default.
- W2577432886 hasConcept C207001950 @default.
- W2577432886 hasConcept C21951064 @default.
- W2577432886 hasConcept C2777199930 @default.